Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
百度集團-SW
09888
5
京東健康
06618
| (Q1)2025/06/30 | (FY)2025/03/31 | (Q1)2024/06/30 | (FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | 3.14%1,894.77億 | -2.08%8,017.53億 | -9.66%1,837.13億 | -6.54%8,187.61億 | -11.48%2,107.76億 | -11.24%2,073.11億 | -10.32%1,973.23億 | 10.29%2,033.51億 | 14.83%8,760.82億 | 16.54%2,381.05億 |
| 主營業務成本 | 6.14%1,063.74億 | -5.86%4,446.11億 | -11.15%1,002.21億 | -2.05%4,722.97億 | -6.50%1,224.86億 | -5.49%1,211.74億 | -2.70%1,158.36億 | 8.53%1,128.01億 | 15.89%4,821.99億 | 15.04%1,309.99億 |
| 毛利 | -0.47%831.03億 | 3.08%3,571.42億 | -7.79%834.92億 | -12.04%3,464.64億 | -17.57%882.9億 | -18.23%861.37億 | -19.31%814.87億 | 12.56%905.5億 | 13.57%3,938.83億 | 18.42%1,071.06億 |
| 營業費用 | -3.17%740.11億 | -3.58%3,003.6億 | 6.17%764.32億 | 5.43%3,115.11億 | 6.87%848.06億 | 8.23%796.62億 | 1.75%750.54億 | 4.71%719.89億 | 13.59%2,954.74億 | 17.63%793.58億 |
| 銷售、一般行政及管理費用 | -2.85%642.5億 | -1.23%2,587.65億 | 4.97%661.35億 | 7.80%2,619.78億 | 4.31%682.7億 | 9.97%677.13億 | 6.42%629.94億 | 10.91%630.01億 | 13.97%2,430.15億 | 15.29%654.47億 |
| -一般及行政管理費用 | -2.85%642.5億 | -1.23%2,587.65億 | 4.97%661.35億 | 7.80%2,619.78億 | 4.31%682.7億 | 9.97%677.13億 | 6.42%629.94億 | 10.91%630.01億 | 13.97%2,430.15億 | 15.29%654.47億 |
| 研發費用 | 12.51%124.77億 | -11.58%443.39億 | -16.27%110.9億 | -0.08%501.44億 | -11.41%122.5億 | -0.22%125.03億 | 0.26%121.46億 | 13.11%132.45億 | 13.34%501.82億 | 23.24%138.27億 |
| 其他營業費用 | -242.50%-27.16億 | -349.10%-27.44億 | 81.37%-7.93億 | -126.83%-6.11億 | 5,002.38%42.86億 | -10.58%-5.54億 | -103.50%-8,600萬 | -1,896.20%-42.57億 | -12.49%22.77億 | 116.00%8,400萬 |
| 營業利潤 | 28.78%90.92億 | 62.45%567.82億 | -61.96%70.6億 | -64.48%349.53億 | -87.44%34.84億 | -79.60%64.75億 | -76.37%64.33億 | 58.67%185.61億 | 13.49%984.09億 | 20.73%277.48億 |
| 營業外利息收入與支出淨額 | ||||||||||
| 投資淨收益 | ||||||||||
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | ||||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | 98.02%-3.88億 | -277.81億 | -195.62億 | 0 | ||||||
| 減:重組及並購 | -98.02%3.88億 | --277.81億 | --195.62億 | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| 其他營業外收入(費用) | ||||||||||
| 稅前利潤 | 169.62%87.04億 | -17.03%290.01億 | -167.36%-125.02億 | -64.48%349.53億 | -87.44%34.84億 | -79.60%64.75億 | -76.37%64.33億 | 58.67%185.61億 | 13.49%984.09億 | 20.73%277.48億 |
| 所得稅 | 154.04%14.57億 | 28.27%134.49億 | -160.95%-26.96億 | -57.96%104.85億 | -78.31%12.73億 | -77.53%19.61億 | -61.85%28.28億 | 50.80%44.23億 | 8.23%249.43億 | -0.64%58.69億 |
| 除稅後利潤 | 176.82%71.89億 | 49.49%148.73億 | -168.93%-93.58億 | -86.65%99.49億 | -95.45%10.66億 | -89.50%24.11億 | -135.40%-71.04億 | 67.81%135.76億 | 20.15%745.45億 | 40.60%234.25億 |
| 持續經營利潤 | 176.82%71.89億 | 49.49%148.73億 | -168.93%-93.58億 | -86.65%99.49億 | -95.45%10.66億 | -89.50%24.11億 | -135.40%-71.04億 | 67.81%135.76億 | 20.15%745.45億 | 40.60%234.25億 |
| 歸屬于少數股東的淨利潤 | 39.18%3.73億 | -175.81%-13.98億 | 48.89%2.68億 | 169.59%18.44億 | 900.00%8.1億 | 99.38%6.42億 | 29.27%2.12億 | 53.85%1.8億 | 6.21%6.84億 | 6.58%8,100萬 |
| 歸屬於母公司的淨利潤 | 170.81%68.16億 | 100.75%162.71億 | -171.86%-96.26億 | -89.03%81.05億 | -98.90%2.56億 | -92.19%17.69億 | -136.76%-73.16億 | 68.02%133.96億 | 20.29%738.61億 | 40.75%233.44億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | 170.81%68.16億 | 100.75%162.71億 | -171.86%-96.26億 | -89.03%81.05億 | -98.90%2.56億 | -92.19%17.69億 | -136.76%-73.16億 | 68.02%133.96億 | 20.29%738.61億 | 40.75%233.44億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | 170.81%34.62 | 100.70%82.63 | -171.84%-48.89 | -88.94%41.17 | -98.90%1.3 | -92.14%8.98 | -137.23%-37.16 | 70.21%68.05 | 21.77%372.19 | 42.26%118.25 |
| 稀釋每股收益 | 170.81%34.62 | 100.70%82.63 | -171.84%-48.89 | -88.94%41.17 | -98.90%1.3 | -92.14%8.98 | -137.23%-37.16 | 70.21%68.05 | 21.77%372.19 | 42.25%118.2409 |
| 每股派息 | 0 | 0.00%104 | 0 | 6.12%104 | 6.12%52 | 0 | 6.12%52 | 0 | 6.52%98 | 6.52%49 |
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |